Delineation of IL-5 domains predicted to engage the IL-5 receptor complex

Journal of Immunology

Volumn 156, Issue 3, 1996, Pages 1030-1037

  Dickason, Richard R ^a   Huston, Marilyn M ^a   Huston, David P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR;

ALLERGIC DISEASE; ARTICLE; ASTHMA; BINDING SITE; CELL DIFFERENTIATION; EOSINOPHIL; GENE MAPPING; HUMAN; HUMAN CELL; INFLAMMATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BINDING, COMPETITIVE; CELL LINE; COMPUTER SIMULATION; EPITOPE MAPPING; GENETIC VECTORS; HUMANS; INTERLEUKIN-5; MICE; MOLECULAR SEQUENCE DATA; RATS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-5; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY;

EID: 0030051655     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Milburn, M V., A. M Hassell, M. H. Lambert, S. R. Jordan, A E. Proudfoot, P. Graber, and T N. Wells. 1993. A novel dimer configuration revealed by the crystal structure at 2.4 Å resolution of human interleukin-5. Nature 363.172.
2. Rozwarski, D. A., A. M. Gronenborn, G. M Clore, J. F. Bazan, A. Bohm, A. Wlodawer, M. Hatada, and P. A. Karplus. 1994 Structural comparison among the short-chain helical cytokines. Structure 2:159.
3. Bazan, J. F., and D. B. McKay. 1992. Unraveling the structure of interleukin-2. Science 257.410.
4. Wlodawer, A, A. Pavlovsky, and A. Gustchina. 1992. Crystal structure of human recombinant interleukin-4 at 2.25 Å resolution. FEBS Lett. 309:59.
5. Diederichs, K., T. Boone, and A. Karplus. 1991. Novel fold and putative receptor binding site of granulocyte-macrophage colony-stimulating factor. Science 254: 1779.
6. Pandit, J., A. Bohm, J. Jancarik, R. Halenbeck, K. Koths, and S. Kim. 1992. Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor. Science 258:1358.
7. McKenzie, A. N., B. Ely, and C. J. Sanderson 1991. Mutated interleukin-5 monomers are biologically inactive Mol Immunol. 28.155.
8. Bohjanen, P. R., M. Okajima, and R. J Hodes. 1990 Differential regulation of interleukin-4 and interleukin-5 gene expression: a comparison of T cell gene induction by anti-CD3 antibody or by exogenous lymphokines. Proc. Natl Acad. Sci. USA 87:5283
9. Dubucquoi, S., P. Desreaumaux, A. Janin, O Klein, M. Goldman, J. Tavernier, A. Capron, and M. Capron. 1994. Interleukin-5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J. Exp. Med. 179:703
10. Plaut, M, J H. Pierce, C J Watson, J Hanley-Hyde, R P. Nordan, and W E. Paul. 1989. Mast cell lines produce lymphokines in response to cross-linkage of Fc∈RI or to calcium ionophores. Nature 339:64.
11. Takaki, S., Y Murata, T Kitamura, A Miyajima, A Tominaga, and K. Takatsu. 1993. Reconstitution of the functional receptors for murine and human interleukin-5. J. Exp. Med. 177:1523.
12. Tavernier, J., R. Devos, S. Cornelis, T. Tuypens, J. Van der Heyden, W. Fiers, and G Plaetinck. 1991. A human high affinity interleukin-5 receptor (IL-5R) is composed of an EL-5-specific α-chain and a β-chain shared with the receptor for GM-CSF Cell 66:1175.
13. Bazan, J F 1990. Structural design and molecular evolution of a cytokine receptor superfamily Proc. Natl. Acad. Sci USA 87:6934
14. Mita, S., A Tominaga, Y. Hitoshi, K Sakamoto, T. Honjo, M. Akagi, Y. Kikuchi, N Yamaguchi, and K. Takatsu 1989. Characterization of high-affinity receptors for interleukin-5 on interleukin-5-dependent cell lines Proc. Natl Acad. Sci. USA 86.2311
15. Murata, Y., S. Takaki, M. Migita, Y. Kikuchi, A Tominaga, and K. Takatsu. 1992. Molecular cloning and expression of the human interleukin-5 receptor J. Exp. Med. 175:341.
16. Karasuyama, H, A. Rolink, and F. Melchers. 1988 Recombinant interleukin-2 or -5, but not -3 or -4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts. J Exp. Med. 167:1377.
17. Webb, C. F., C. Das, S. Eaton, K Calame, and P W. Tucker. 1991 Novel protein-DNA interactions associated with increased immunoglobulin transcription in response to antigen plus interleukin-5. Mol. Cell. Biol. 11-5197.
18. Ramos, T. 1989. Interleukin-5 is a differentiation factor for cytotoxic T lymphocytes. Immunol. Lett. 21:277.
19. Martinez, O. M., and S M. Krams. 1993. Human interleukin-5 augments interleukin-2-dependent T cell proliferation J. Immunol 150 45 (Abstr).
20. Aoki, T., H Kikuchi, S. Miyatake, Y. Oda, K. Iwasaki, T. Yamasaki, T Kinashi, and T. Honjo. 1989 Interleukin-5 enhances interleukin-2-mediated lymphokine-activated killer activity. J. Exp. Med. 170:583.
21. Denburg, J A. 1992 Basophil and mast cell lineages in vitro and in vivo. Blood 79:846.
22. Bischoff, S. C., T. Brunner, A. L De Weck, and C. A. Dahinden 1990. Interleukin-5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp. Med. 172:1577.
23. Clutterbuck, E J, E. M Hirst, and C. J. Sanderson. 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures. comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF. Blood 73:1504.
24. Yamaguchi, Y., T. Suda, S. Ohta, K. Tominaga, Y. Miura, and T. Kasahara 1991. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 78:2542
25. Walsh, G. M., A. J. Wardlaw, A. Hartnell, C J. Sanderson, and A. B Kay. 1991 Interleukin-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Int Arch. Allergy Appl. Immunol. 94 174.
26. Fujisawa, T., R. Abu-Ghazaleh, H. Kita, C. J. Sanderson, and G. J. Gleich 1990. Regulatory effect of cytokines on eosinophil degranulation. J Immunol. 144 642.
27. Lopez, A. F., C. J Sanderson, J R. Gamble, H D. Campbell, I. G Young, and M. A. Vadas 1988. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J. Exp. Med 167:219
28. Lopez, A. F., C. G. Begley, D. J. Williamson, D J Warren, M. A Vadas, and C. J. Sanderson. 1986. Murine eosinophil differentiation factor: an eosinophil-specific colony-stimulating factor with activity for human cells. J Exp. Med 163 1085
29. Yamaguchi, Y., Y. Hayashi, Y Sugama, Y. Miura, T Kasahara, S. Kitamura, M. Torisu, S. Mita, A. Tominaga, and K Takatsu. 1988 Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival IL-5 as an eosinophil chemotactic factor. J. Exp Med. 167.1737.
30. Motojima, S., I Akutsu, T. Fukuda, S. Makino, and K. Takatsu. 1993. Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma Allergy 48:98.
31. Saito, H, K. Asakura, and A. Kataura. 1994. Study of the interleukin-5 expression in allergic nasal mucosa Int. Arch. Allergy Appl. Immunol 104:539.
32. Kodama, S, N. Tsuruoka, and M. Tsujimoto. 1991. Role of the C-terminus in the biologic activity of human interleukin-5. Biochem. Biophys. Res. Commun. 178: 514.
33. McKenzie, A. N., S. C. Barry, M. Strath, and C. J. Sanderson. 1991. Structure-function analysis of interleukin-5 utilizing mouse/human chimeric molecules. EMBO J. 10:1193.
34. Shanafelt, A. B, A. Miyajima, T. Kitamura, and R. A. Kastelein. 1991. The amino-terminal helix of GM-CSF and IL-5 governs high affinity binding to their receptors EMBO J 10:4105.
35. Dickason, R R., M. M Huston, and D P. Huston. 1994. Enhanced detection of human interleukin-5 in biologic fluids utilizing murine monoclonal antibodies which delineate distinct neutralizing epitopes. Cytokine 6:647.
36. Schumacher, J. H., A. O'Garra, B. Shrader, A. van Kimmenade, M. W. Bond, T. R. Mosmann, and R. L Coffman. 1988 The characterization of four monoclonal antibodies specific for mouse interleukin (IL)-5 and development of mouse and human IL-5 enzyme-linked immunosorbent. J. Immunol. 141:1576.
37. Kitamura, T., T. Tange, T Terasawa, S Chiba, K. Kuwaki, K. Miyagawa, Y. F Piao, K. Miyazano, A. Urabe, and F. Takaku. 1989. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol. 140:323.
38. Uberla, K., W Q. Li, Z. H. Qin, G. Richter, T. Raabe, T. Diamantstein, and T. Blankenstein. 1991. The rat interleukin-5 gene: characterization and expression by retroviral gene transfer and polymerase chain reaction Cytokine 3:72.
39. Tsuruoka, N., K Yamashiro, and M. Tsujimoto. 1993. Purification of soluble murine interleukin-5 (IL-5) receptor a expressed in Chinese hamster ovary cells and its action as an TL-5 antagonist. Arch. Biochem. Biophys. 307.133.
40. Tsuruoka, N., K Funakoshi, S. Kodama, and M. Tsujimoto. 1990. Interaction of interleukin-5 with its receptors on murine leukemic BCL1 cells and its implication in biologic activity. Cell. Immunol. 125:354.
41. Graber, P. A. E. I. Proudfoot, R. Talabot, A. Bernard, M. McKinnon, M Banks. D. Fatiah, R. Solari, M. C. Peitsch, and T. N. C. Wells. 1995. Identification of key charged residues of human interleukin-5 in receptor binding and cellular activation. J. Biol. Chem. 270:15762
42. Tavernier, J., T. Tuypens, A. Verhee, G. Plaetinck, R. Devos, J. Van der Heyden, Y Guisez, and C. Oefner. 1995. Identification of receptor binding domains on human interleukin-5 and design of an interleukin-5-derived receptor antagonist. Proc. Natl. Acad Sci. USA 92:5194.
43. Cornelis, S., G. Plaetinck, R. Devos, J. Van der Heyden, J. Tavernier, C. J. Sanderson, Y Guisez, and W. Fiers. 1995. Detailed analysis of the IL-5-IL-5Rα interaction characterization of crucial residues on the ligand and the receptor. EMBO J. 14:3395.